• 1. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Professional Introduction to Ethyl 4-Methylpyridine-3-Carboxylate Hydrochloride (CAS No. 6316-72-9)

Ethyl 4-methylpyridine-3-carboxylate hydrochloride, with the CAS number 6316-72-9, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This compound has garnered attention due to its versatile applications in drug synthesis and as an intermediate in the development of various bioactive molecules. The structure of this compound, featuring a pyridine core with ester and hydrochloride functional groups, makes it a valuable building block for medicinal chemists.

The 4-methylpyridine-3-carboxylate moiety is particularly noteworthy for its role in enhancing the pharmacokinetic properties of drug candidates. Recent studies have highlighted its potential in the synthesis of novel antiviral and anti-inflammatory agents. The hydrochloride salt form of this compound improves its solubility in water, making it more suitable for formulation into oral and injectable medications.

In the realm of drug discovery, ethyl 4-methylpyridine-3-carboxylate hydrochloride has been employed in the development of small-molecule inhibitors targeting various enzymes and receptors. For instance, researchers have utilized this compound as a precursor in the synthesis of molecules that inhibit Janus kinases (JAKs), which are implicated in autoimmune diseases such as rheumatoid arthritis. The ability to modulate JAK activity has significant therapeutic implications, and ethyl 4-methylpyridine-3-carboxylate hydrochloride plays a crucial role in this process.

Moreover, the compound's structural features have made it a candidate for further derivatization to explore new pharmacological profiles. By introducing different substituents or altering the ester group, chemists can generate a library of analogs with tailored biological activities. This approach is particularly valuable in fragment-based drug design, where small molecular fragments are modified to improve binding affinity and selectivity.

The pharmaceutical industry has also shown interest in ethyl 4-methylpyridine-3-carboxylate hydrochloride for its potential use in central nervous system (CNS) drug development. Pyridine derivatives are known for their ability to cross the blood-brain barrier, making them suitable candidates for treating neurological disorders. Preliminary studies suggest that derivatives of this compound may exhibit neuroprotective and anti-depressant effects, although further research is needed to fully elucidate their mechanisms of action.

From a synthetic chemistry perspective, ethyl 4-methylpyridine-3-carboxylate hydrochloride serves as a versatile intermediate. Its reaction with various nucleophiles allows for the introduction of diverse functional groups, enabling the construction of complex molecular architectures. This flexibility is particularly advantageous in the synthesis of heterocyclic compounds, which are prevalent in many therapeutic agents.

The compound's stability under various conditions makes it a reliable choice for industrial-scale synthesis. Additionally, its well-documented safety profile and ease of handling contribute to its popularity among researchers and manufacturers alike. These attributes ensure that ethyl 4-methylpyridine-3-carboxylate hydrochloride remains a cornerstone in pharmaceutical research and development.

In conclusion, ethyl 4-methylpyridine-3-carboxylate hydrochloride (CAS No. 6316-72-9) is a multifaceted compound with significant applications in pharmaceutical chemistry. Its role as an intermediate in drug synthesis and its potential as a precursor for bioactive molecules underscore its importance in modern medicinal chemistry. As research continues to uncover new therapeutic applications, this compound is poised to remain a key player in the development of innovative treatments for various diseases.

• 58997-11-8(Ethyl 3-methylisonicotinate)
• 466-48-8(Aspidospermidine,17-methoxy-1-(1-oxopropyl)- (9CI))
• 4664-08-8(3,4-Pyridinedicarboxylic anhydride)
• 1678-52-0(3,4-diethyl pyridine-3,4-dicarboxylate)
• 1796-83-4(3,4-dimethyl pyridine-3,4-dicarboxylate hydrochloride)
• 33402-75-4(Methyl 4-methylnicotinate)
• 24202-79-7(3-(methoxycarbonyl)pyridine-4-carboxylic acid)
• 24202-74-2(4-(methoxycarbonyl)pyridine-3-carboxylic acid)
• 2199-49-7(Ethyl 4-methyl-1h-pyrrole-3-carboxylate)
• 5657-52-3(Furo[3,4-c]pyridin-3(1H)-one)